The Business Research Company's Promacta Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at ...
In fact, Novartis already expects U.S. competition for Entresto, Tasigna and Promacta to begin in mid-2025. Tasigna is a cancer drug, while Promacta treats low blood platelets. The latter drugs ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈